Full-thickness human skin-on-chip research and first stem cells using CRISPR genome activation
Get all updates at the 3D Cell Culture Conference, 21 - 22nd February 2018, London, UK
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh